Clinical Trials Sponsored by Danægg
Total 299 results
-
Danang Psychiatric HospitalCompleted
-
University of OsloNofima; Norwegian University of Life Sciences; Nortuna; Norilia; Orkla; DanæggCompleted
-
Chong Kun Dang PharmaceuticalNot yet recruiting
-
Chong Kun Dang PharmaceuticalRecruitingType 2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalRecruitingCOVID-19 PneumoniaKorea, Republic of
-
Chong Kun Dang PharmaceuticalNot yet recruitingKidney TransplantationKorea, Republic of
-
Chong Kun Dang PharmaceuticalActive, not recruiting
-
Chong Kun Dang PharmaceuticalCompletedType II DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDiabetes type2Korea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHealthy SubjectsUnited Kingdom
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedClinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy VolunteersChronic Renal FailureKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedAlopeciaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedEfficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 DiabetesType2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedChronic Hepatitis BKorea, Republic of
-
Chong Kun Dang PharmaceuticalActive, not recruitingKidney TransplantKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedNeovascular(Wet) Age Related Macular DegenerationKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownAnticoagulantKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalUnknownLiver TransplantKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType 2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedFungal Infections | Candida Infections | Aspergillus InfectionsKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownMyeloma, MultipleKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedRespiratory InfectionKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedCardiovascular DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedCardiovascular DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedStudy to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy VolunteersRheumatoid ArthritisKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedRheumatoid ArthritisKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknown
-
Chong Kun Dang PharmaceuticalUnknownType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownKidney TransplantKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownType2 Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownHypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownOcular Hypertension | Primary Open-angle GlaucomaKorea, Republic of